Ridgewood Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,500
| Closed | -$11.3K | – | 694 |
|
2023
Q2 | $11.3K | Hold |
1,500
| – | – | 0.01% | 499 |
|
2023
Q1 | $13.3K | Buy |
+1,500
| New | +$13.3K | 0.01% | 488 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 193 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 197 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 212 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 198 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 196 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 203 |
|
2018
Q2 | – | Sell |
-13,211
| Closed | -$226K | – | 159 |
|
2018
Q1 | $226K | Sell |
13,211
-108
| -0.8% | -$1.85K | 0.21% | 133 |
|
2017
Q4 | $252K | Sell |
13,319
-15
| -0.1% | -$284 | 0.23% | 127 |
|
2017
Q3 | $235K | Buy |
13,334
+4,497
| +51% | +$79.3K | 0.22% | 125 |
|
2017
Q2 | $294K | Buy |
8,837
+774
| +10% | +$25.8K | 0.29% | 103 |
|
2017
Q1 | $259K | Buy |
8,063
+1,007
| +14% | +$32.3K | 0.28% | 102 |
|
2016
Q4 | $255K | Buy |
+7,056
| New | +$255K | 0.3% | 92 |
|